RobertJ.RushakoffMD
Endocrinology • San Francisco, CADiabetes, Lipid Metabolism
Professor of Medicine, UCSF
Dr. Rushakoff is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1600 Divisadero St
San Francisco, CA 94143Phone+1 415-885-3868Fax+1 415-884-7724
Education & Training
Cedars-Sinai Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1986 - 1987
University of California (San Francisco)/Mount ZionResidency, Internal Medicine, 1982 - 1985
Medical College of WisconsinClass of 1982
Certifications & Licensure
CA State Medical License 1984 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2011-2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Hyperglycemia in Renal Transplantation Start of enrollment: 2012 Aug 01
- Hypoglycemia Prediction Model Start of enrollment: 2017 Jan 01
Publications & Presentations
PubMed
- Insulin icodec use in hospital settings: Considerations for once-weekly basal insulin therapy in hospital glycaemic management practice.Rahul D Barmanray, Mervyn Kyi, Gerry Rayman, Robert Rushakoff, Philip Newland-Jones
Diabetes Research and Clinical Practice. 2024-05-01 - 1 citationsNovel Automated Self-adjusting Subcutaneous Insulin Algorithm Improves Glycemic Control and Physician Efficiency in Hospitalized Patients.Paras B Mehta, Michael A Kohn, Esther Rov-Ikpah, Craig San Luis, Craig Johnson
Journal of Diabetes Science and Technology. 2024-05-01 - Outcomes and Adverse Events in Patients with Cancer after Diagnosis of Immunotherapy-Associated Diabetes Mellitus: A Retrospective Cohort Study.Eva Duvalyan, Sam Brondfield, Robert J Rushakoff, Mark S Anderson, Zoe Quandt
Cancers. 2024-04-25
Journal Articles
- Collateral Damage: Insulin-Dependent Diabetes Induced with Checkpoint InhibitorsRobert Rushakoff, Zoe Quandt, James Lee, Kevan C Herold, Diabetes Care
Press Mentions
Dilemmas in DiabetesDecember 9th, 2019
Many People with Diabetes Can't Afford 'Good' Insulin. What Should They Know About Switching to the Cheaper Stuff?August 20th, 2019
Diabetes After 50 Could Be Early Sign of Pancreatic Cancer, Study SaysJune 19th, 2018- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
